Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
about
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletionsLong noncoding RNAs in cancer: mechanisms of action and technological advancementsLong Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic TargetsLong non-coding RNA-dependent transcriptional regulation in neuronal development and diseaseLong non-coding RNA: a new player in cancerANRIL: molecular mechanisms and implications in human healthBioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and ChallengesLong noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449aEchocardiographic evidence of innate aortopathy in the human intracranial aneurysm.High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis.MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesisLncRNA pathway involved in premature preterm rupture of membrane (PPROM): an epigenomic approach to study the pathogenesis of reproductive disorders.The role of long non-coding RNAs in genome formatting and expressionA central role for long non-coding RNA in cancerJunk DNA and the long non-coding RNA twist in cancer genetics.Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy.Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders.Conceptual approaches for lncRNA drug discovery and future strategies.Macro lncRNAs: a new layer of cis-regulatory information in the mammalian genome.Long non-coding RNAs and human disease.Long noncoding RNA involvement in cancerLong noncoding RNA: an emerging paradigm of cancer research.ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.Downregulation of lncRNA-MALAT1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S.Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.The NF1 gene in tumor syndromes and melanoma.NF1 single and multi-exons copy number variations in neurofibromatosis type 1.Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing.Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome.Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
P2860
Q21261481-B70E095F-6274-4AFE-ABF3-3FF1DDF80F66Q26745528-A1A2BAC9-FBE9-4AC9-AAAC-C94C77CDA404Q26785935-35CBFD8F-9D19-454E-93BE-4A3989D366CEQ26999388-8DE135FB-FCF4-4339-80F4-A5ED919E84CBQ27000700-0A780EAC-79E8-4B69-9F1E-1496BB42B78BQ28394102-1FD6C391-58F6-4457-B79E-8B9CC42A37C5Q28710308-2E369364-3AE3-4767-BBEB-A0070E7D575DQ33688606-915A89E1-409E-40B3-A954-82E06486D360Q33806785-B26D1120-4E8E-4A9C-B5B4-DBF4B89BC57BQ33898623-179350A6-7A75-4C49-B256-96A5439E7C43Q34379695-A70F6424-24A7-45F0-9280-F8C955F6C72AQ34814749-81F1E1D3-81BE-4955-87AE-1AC5591C2B6FQ35060216-7951FF7B-9DF6-4028-B7D6-3412AA26FBCAQ35550745-D9823092-DC30-47CE-A82C-8D6F2864F21BQ35757646-C8E57F7A-EC5E-4D98-BB7F-34234E1A79B5Q36004601-B09DFD5A-62D1-4EA2-A9DE-EFA33BD8C8E4Q37249139-518B12F6-1250-471D-8CB7-301EF3CFBF1CQ37582014-ACF2FC3D-478D-4F51-B335-B4879D788D2AQ37641678-CC997E7A-2C63-4E42-9AC1-87989856BA04Q37989144-426FEC41-41B4-4890-A2D0-08B4DE7F47E8Q38007555-EFD23A94-DC9E-4C9C-A228-4CBF6700918FQ38012332-0765494C-645E-4F0D-9790-F51CAEF02661Q38027980-265B8FF6-C4C1-4419-A41D-18DC0C79E0F6Q38063049-6574EDB6-BAC6-48C9-8137-EF28EE3C38FBQ38077502-1BA8460D-A900-4AC2-A389-21AE5D580845Q38692678-51C97646-17DB-48BD-89D1-2329D1937FA9Q38797046-613CA611-BF08-46AB-850F-300E50DBFD25Q38813218-79798A52-77B8-496A-8D5A-00F47BC1AC2AQ38998127-073EF124-DF66-4D3B-8A97-3CE136CD90A8Q39031599-AAFB0445-25C7-493F-840A-DB60071A3421Q39076849-EA2C54D6-64B6-4D5B-B40C-40C61562640DQ41516419-A2BAE7E3-3B31-4A5E-9D15-E82F6F6B5C70Q46006380-2773953C-5A7B-4EE6-93BB-D434D27581D8Q46339754-81DF9514-10C9-4228-BC96-2645E7C20A4FQ47262034-26E50518-BEAD-4248-A692-3721459D205EQ47393672-5940290A-B1F9-41E0-A716-11758C7B37B2Q52674888-3BC03700-5A78-476B-ADFA-8BC94DFC8605Q54435178-285C674C-3044-43FE-BE14-D5A3BE65E5E1Q57817505-B5732859-98B8-4F90-A725-78545C91C60C
P2860
Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Role of noncoding RNA ANRIL in ...... s in neurofibromatosis type 1.
@en
Role of noncoding RNA ANRIL in ...... s in neurofibromatosis type 1.
@nl
type
label
Role of noncoding RNA ANRIL in ...... s in neurofibromatosis type 1.
@en
Role of noncoding RNA ANRIL in ...... s in neurofibromatosis type 1.
@nl
prefLabel
Role of noncoding RNA ANRIL in ...... s in neurofibromatosis type 1.
@en
Role of noncoding RNA ANRIL in ...... s in neurofibromatosis type 1.
@nl
P2093
P2860
P50
P356
P1476
Role of noncoding RNA ANRIL in ...... as in neurofibromatosis type 1
@en
P2093
Béatrice Parfait
Dominique Vidaud
Ingrid Laurendeau
Julien Masliah-Planchon
Laurence Valeyrie-Allanore
Laurent Lantieri
Lucie Hernandez
Lucie Melin
Michel Vidaud
Pierre Wolkenstein
P2860
P304
P356
10.1093/JNCI/DJR416
P407
P577
2011-10-27T00:00:00Z